These findings show that disulfiram treatment affects the expression of additional genes regulated by MLL1 and MLL2, and that disulfiram can be used to disrupt the expression of HOX genes, which are frequently associated with tumorigenesis in high-grade glioma [3]. This evidence concerns the gene KMT2A and central nervous system cancer.